EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Slo1 Deficient Myoblast Exosomes‐Derived miR‐222‐3p Inhibits Osteogenic Differentiation via Targeting of STAT3

Yonghui Wang, Xinrun Ma, Yang Chen, Chao Xia, Xue Lei, Junran Liu, Yunyi Jiang, Rang Xu, Yanhong Gao

Journal of Cachexia, Sarcopenia and Muscle · 2025

DOI: 10.1002/jcsm.70115 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cachexia, Sarcopenia and Muscle, 2025. Verfasst von Yonghui Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, Xinhua Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: MicroRNAs, Exosomes, Osteogenesis, Myoblasts. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key R&D Program of China, Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Previous research has shown that the conditional knockout of Slo1 in muscle leads to a reduction in muscle strength and inhibits myogenic differentiation. Exosomes are emerging as necessary mediators of the crosstalk between muscle and bones. The present study focused on the communication between muscle and bone to investigate the effects and mechanisms of skeletal muscle‐specific knockout of Slo1 on bone mass and bone metabolism.

Methods

Myf5‐Cre mice were mated with Slo1 flox/flox mice to construct skeletal muscle‐specific Slo1 knockout mice (CKO mice). The legs of the Slo1 CKO mice were isolated, and a series of examinations were conducted to monitor bone mineral density (BMD) and bone microstructure. Exosomes were extracted from C2C12‐shNC and C2C12‐shSlo1 cells and subjected to transmission electron microscopy (TEM), nanoparticle tracking analysis (NTA) and Western blotting (WB). The osteogenic effect of EXO‐shSlo1 was examined in vitro and in vivo by Alkaline phosphatase (ALP) staining, q‐PCR, WB and microCT. RNA sequencing (RNA‐seq) analysis of EXO‐shNC and EXO‐shSlo1 was used to identify differentially expressed microRNAs. Mimics and inhibitors of miR‐222‐3p were transfected into MC3T3‐E1 cells to induce differentiation. The predicted targets of miR‐222‐3p were examined with Luciferase, qPCR, and WB.

Results

In Slo1 CKO mice, the bone mass decreased, and the microstructure was disrupted. TEM, NTA and WB assays showed that Slo1‐silenced C2C12 cells secreted exosomes and localized to MC3T3‐E1 cells and bone tissue through the circulation. EXO‐shSlo1 inhibited osteogenesis both in vivo and in vitro, as demonstrated by the decreased ALP activity (~40%, p < 0.05), osteogenic marker expression (~30%, p < 0.05), mineral deposition in osteoblasts and BMD. qPCR was performed to confirm the exosome RNA‐seq results, which indicated that miR‐222‐3p was increased by three times in the EXO‐shSlo1 group compared with the EXO‐shNC group. Transfection of mimics or inhibitors of miR‐222‐3p in MC3T3‐E1 cells inhibited or improved osteogenic differentiation. Luciferase reporter assays revealed that miR‐222‐3p targets STAT3. The mRNA and protein level of STAT3 was affected by miR‐222‐3p. Through inhibiting miR‐222‐3p or upregulating STAT3, the EXO‐shSlo1‐mediated osteogenic inhibition of MC3T3‐E1 cells was ameliorated, as indicated by increased ALP activity and osteogenic marker expression.

Conclusion

Slo1 deficiency in muscle results in decreased bone mass mediated by exosomal miR‐222‐3p. MiR‐222‐3p binds and inhibits the transcription of STAT3 to suppress the differentiation of osteoblasts. Slo1‐silenced myoblasts‐derived exosomal miR‐222‐3p inhibit osteogenesis and cause bone loss through the miR‐222‐3p/STAT3 pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsExosomesOsteogenesisMyoblastsSTAT3 Transcription FactorAnimalsMiceCell DifferentiationMice, Knockout

Stichwörter der Autor:innen

STAT3Slo1boneexosomesmiR‐222‐3p

Substanzen

MicroRNAsSTAT3 Transcription FactorMIRN222 microRNA, mouseStat3 protein, mouse

Autor:innen und Institutionen

  • Department of Geriatrics, Xinhua Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.
  • Department of Geriatrics, Shanghai General Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.
  • Department of Endocrinology and Metabolism, Shanghai Ninth People's Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.
  • Scientific Research Center, Xinhua Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.

Förderung

  • National Key R&D Program of China
  • Fundamental Research Funds for the Central Universities
  • National Natural Science Foundation of China
  • Science and Technology Commission of Shanghai Municipality
  • Shanghai Municipal Health Commission
  • National Key Research and Development Program of China

Zitieren

APA

Wang, Y., Ma, X., Chen, Y., Xia, C., Lei, X., Liu, J., Jiang, Y., Xu, R., & Gao, Y. (2025). Slo1 Deficient Myoblast Exosomes‐Derived miR‐222‐3p Inhibits Osteogenic Differentiation via Targeting of STAT3. Journal of Cachexia, Sarcopenia and Muscle. https://doi.org/10.1002/jcsm.70115

Vancouver

Wang Y, Ma X, Chen Y, Xia C, Lei X, Liu J, et al. Slo1 Deficient Myoblast Exosomes‐Derived miR‐222‐3p Inhibits Osteogenic Differentiation via Targeting of STAT3. Journal of Cachexia, Sarcopenia and Muscle. 2025. doi:10.1002/jcsm.70115

BibTeX
@article{Wang2025,
  author = {Wang, Yonghui and Ma, Xinrun and Chen, Yang and Xia, Chao and Lei, Xue and Liu, Junran and Jiang, Yunyi and Xu, Rang and Gao, Yanhong},
  title = {Slo1 Deficient Myoblast Exosomes‐Derived miR‐222‐3p Inhibits Osteogenic Differentiation via Targeting of STAT3},
  journal = {Journal of Cachexia, Sarcopenia and Muscle},
  year = {2025},
  doi = {10.1002/jcsm.70115}
}
Kostenlos starten →